SectorBiological Technology
Established Date--
Listing Date30/01/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees21
Fiscal Year Ends31/12
Security TypeCommon stock
Office address245 First Street, 18th Floor, Cambridge, Massachusetts 02142
Business
IntroductionBlack Diamond Therapeutics, Inc., was incorporated in Delaware in December 2014. The company is a clinical-stage oncology company focused on developing MasterKey therapies for the treatment of patients with genetically defined tumors. The company's goal is to genetically define cancer-causing driver mutations in cancer patients where drugs do not exist.
